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 MOST industrialized countries will need to adapt their health care systems to meet the challenges arising 
from population aging. This will require meaningful esti-
mates of population health from epidemiological surveys. 
Functional impairments in the oldest age group have been 
discussed with regard to current and projected long-term care 
needs; however, this limits the view of the future needs of 
aging populations. In Europe, the large cohort of post – World 
War II baby boomers will reach retirement age over the next 
two decades. And although preventing an unfavorable evolu-
tion toward loss of autonomy in this generation is a public 
health priority, little is known regarding the proportion at risk 
for functional decline in middle age and beyond. Health indi-
cators based on selected chronic conditions or unhealthy be-
haviors are diffi cult to interpret because multiple combinations 
of degenerative diseases result in considerable heterogeneity 
in the risk for functional loss and health care needs. 
 Thus, the geriatric concept of frailty ( 1 – 3 ) is of particu-
lar interest because frailty is likely to be a precursor of dis-
ability ( 4 – 6 ) and may be reversible in its early stages ( 7 ). 
The prevalence of frailty might summarize health and the 
needs for prevention in middle-aged and older populations 
( 8 , 9 ). A major impediment to measuring frailty in popula-
tion-based surveys is the lack of an operational defi nition. 
However, Fried and colleagues ( 4 , 10 ) identifi ed a frailty 
phenotype that was predictive of adverse outcomes such as 
falls and fractures ( 11 , 12 ), mobility and functional declines 
( 4 , 5 , 12 ), hospitalizations ( 4 ), nursing home admissions ( 5 ), 
and death ( 4 – 6 , 11 – 13 ). The prevalence of this phenotype 
has mainly been estimated for Northern America and scant 
data are available for Europe ( 14 , 15 ). The population of Eu-
ropean countries could experience different levels of frailty 
due to cultural, regional, or political distinctions. 
 The purposes of this study were to quantify the preva-
lence of frailty in community-dwelling middle-aged and 
older Europeans participating in the Survey of Health, Ag-
ing and Retirement in Europe (SHARE) in 2004, compare 
this prevalence among the 10 countries included in this sur-
vey, and evaluate selected population characteristics as po-
tential explanations for international differences observed 
in the 65 years and older (65+) subgroup. 
 Methods 
 Data Source and Participants 
 SHARE is a multidisciplinary European Union research 
project ( 16 ) covering 10 countries in its 2004 fi rst wave: 
Austria, Denmark, France, Germany, Greece, Italy, the 
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Netherlands, Spain, Sweden, and Switzerland. Probability 
samples were selected in each country, using sampling tech-
niques adapted to the local conditions ( 17 ). Baseline data 
were collected from 24,690 individuals living in households 
that included at least one member who was 50 years of age 
or older. All household members in this age category and 
their spouses of whatever age were eligible; some countries 
also included institutionalized individuals. The overall re-
sponse rate was 61.8% ( Table 1 ), varying across countries 
from 50.2% to 73.6%, except in Switzerland, which had a 
particularly low response rate (37.6%) ( 18 ). 
 After excluding 5,431 individuals from additional sam-
ples drawn in some countries for a supplementary survey, 
674 spouses younger than 50 years, 295 individuals living 
in institutions, 61 with insuffi cient information on sampling 
characteristics, and 2 nonevaluable individuals, 18,227 
community-dwelling individuals were eligible for analysis. 
 Data Collection and Measurements 
 The survey was based on standardized computer-assisted 
face-to-face personal interviews conducted by trained ( 19 ) 
and supervised interviewers using a common questionnaire 
translated from a generic English version (available online 
at http://www.share-project.org/) ( 20 ). Interviews were sup-
plemented by measurements of handgrip strength in all par-
ticipants and a 2.5-m walking test in participants 75 years of 
age and older. 
 Variables Defi nition 
 Frailty and prefrailty were defi ned on the basis of the fi ve 
dimensions in a phenotype described by Fried and associ-
ates ( 4 ). However, operationalization of these dimensions 
required adaptation to our survey contents. Exhaustion was 
identifi ed as a positive response to the question,  “ In the last 
month, have you had too little energy to do things you 
wanted to do? (yes/no). ” The shrinking criterion was ful-
fi lled by reporting a  “ diminution in desire for food ” in re-
sponse to the question,  “ What has your appetite been like ” 
or, in the case of an uncodable response to this question, by 
responding  “ less ” to the following question:  “ So have you 
been eating more or less than usual?. ” Weakness was de-
rived from the highest of four consecutive dynamometer 
measurements of handgrip strength (two from each hand), 
applying gender and body mass index cutoffs set by Fried 
and associates. Because SHARE measured walking speed 
only in individuals 75 years of age and older, slowness was 
defi ned using mobility questions, after previous analysis 
showed a strong relationship between low speed and posi-
tive answers to either of the following two items:  “ Because 
of a health problem, do you have diffi culty [expected to last 
more than 3 months] walking 100 meters ” or  “ … climbing 
one fl ight of stairs without resting ” ( 21 ). The low activity 
criterion was fulfi lled in participants responding  “ one to 
three times a month ” or  “ hardly ever or never ” to the ques-
tion,  “ How often do you engage in activities that require a 
low or moderate level of energy such as gardening, cleaning 
the car, or going for a walk?. ” One point was allocated for 
each fulfi lled criterion; individuals with zero points were 
classifi ed as nonfrail, with one or two points as prefrail and 
with three to fi ve points as frail. Participants with health-
related diffi culties in one or more of the fi ve Katz basic ac-
tivities of daily living (eating, bathing or showering, 
dressing, transferring, using the toilet) for at least 3 months 
were considered disabled. 
 Statistical Analysis 
 A cross-sectional analysis of SHARE wave 1 (baseline) 
was performed with Stata 9.0 version 2.0.1, which includes 
design weights for multistage sampling design and calibra-
tion to population totals within countries to refl ect national 
populations ( 17 ). Population characteristics in middle (50 –
 64 years) and old (65+ years) ages were fi rst described over-
all and in each country by computing the prevalence 
estimates with 95% confi dence intervals (CIs). International 
differences in the prevalences of frailty and prefrailty were 
then explored in the subset of older individuals (65+ years) 
without disability using multivariate logistic regression 
 Table 1.  Overall Response Rate in SHARE Wave 1 (2004), Working Sample Size and Age Distribution 
 Overall Response Rate (%) Working Sample Size ( N )
Weighted * Proportion 
50 – 64 y of Age (%)
Weighted * Mean ( SD ) 
Age in 65+ Category (y) 
 Sweden 50.2 2,050 51.5 75.2 (7.6) 
 Denmark 63.2 1,572 58.7 74.7 (6.9) 
 The Netherlands 61.3 2,221 59.3 73.9 (6.4) 
 Germany 63.4 2,278 50.6 73.8 (6.9) 
 Austria 58.1 1,829 53.2 74.2 (6.7) 
 Switzerland 37.6 938 55.2 74.5 (7.2) 
 France 73.6 1,651 51.5 74.8 (6.9) 
 Italy 55.1 1,971 48.7 74.2 (6.8) 
 Spain 53.3 1,762 47.3 75.0 (7.1) 
 Greece 61.4 1,955 50.4 73.8 (6.9) 
 All 10 countries 61.8 18,227 50.7 74.3 (6.9) 
 Notes : SHARE = Survey of Health, Aging and Retirement in Europe. 
 * Accounting for the primary sampling unit, the strata, and the calibrated individual weight. 
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models, adjusting fi rst only for gender and age (in years) 
and then for both demographics and education (number of 
years) as an indicator of socioeconomic status; the outcome 
was frailty in Model 1, and either prefrailty or frailty in 
Model 2. Germany was chosen as the reference country, 
based on both statistical (large sample size) and geographi-
cal (central location in Europe) considerations. Adjusted 
odds ratios and 95% CIs were calculated for country effects. 
The signifi cance level was set at  p < .01 to account for mul-
tiple comparisons during interpretation. Results are pre-
sented for countries sorted from north to south based on 
their mean latitude. 
 Results 
 Of 18,227 participants 50 years of age and older, 9.0% 
had missing information on one or two dimensions of frailty, 
leaving 16,584 participants for analysis. In the middle-aged 
population, 4.1% (95% CI 3.4 – 4.7) were frail and 37.4% 
(35.8 – 39.1) were prefrail. A sensitivity analysis conducted 
on 18,227 observations with imputation of zero for up to 
two missing values on frailty criteria produced slightly 
higher estimates of the prevalence of frailty and prefrailty, 
with differences never exceeding 1.7% in both age catego-
ries (data not shown, results available upon request). Women 
were more frequently frail and prefrail (5.2% [4.3 – 6.1] and 
42.0% [40.0 – 44.0], respectively) than men (2.9% [2.0 – 3.8] 
and 32.7% [30.5 – 34.9], respectively;  p < .001). In the 65+ 
group, 17.0% (15.3 – 18.7) were frail and 42.3% (40.5 – 44.1) 
prefrail, with frailty and prefrailty noted in 21.0% (18.6 –
 23.3) and 42.7% (40.2 – 45.1), respectively, of women, and 
in 11.9% (10.3 – 13.6) and 41.9% (39.5 – 44.2), respectively, 
of men ( p < .001). 
 Table 2 shows signifi cant country differences in the prev-
alences of frailty criteria and frailty status. In both age cat-
egories, frailty and prefrailty were particularly frequent in 
Spain and, to a lesser extent, in Italy. All frailty criteria ex-
cept low physical activity had a higher prevalence in Spain. 
Weakness, slowness, and low physical activity were fre-
quent in Italy in the 65+ group. In contrast, Sweden and 
Switzerland were characterized by a low prevalence of 
frailty. Their profi les were particularly favorable in the 
dimensions of slowness and physical activity. 
 Table 2 also shows differences in the prevalence of dis-
ability for those in the 65+ group, ranging from 8.4% in 
Austria to more than 16.2% in Italy.  Figure 1 indicates a 
high prevalence of frailty in southern countries (Spain, Italy, 
France, and Greece). A high frequency of disability was 
also recorded for Spain, Italy, and France ( Table 2 ). How-
ever, in the nondisabled population, frailty was again found 
to be more common in southern Europe (21.0% in Spain, 
14.3% in Italy, 11.3% in Greece, 9.3% in France), whereas 
its prevalence was lower than 9.0% in all other countries 
( Figure 2 ). Prefrailty was also most frequent in Spain, Italy, 
and Greece. 
 Table 3 (upper) shows unadjusted country effects. In ad-
justed multivariate analysis controlling for demographics 
only, these effects did not change substantially (data not 
shown, available upon request): Frailty remained more fre-
quent in Spain and Italy and less frequent in Switzerland as 
compared with Germany (Model 1). In contrast, the four 
southernmost European countries included in SHARE had a 
higher age- and gender-adjusted proportion with signs of 
prefrailty or frailty (Model 2). However, the estimates of 
country effects changed markedly after simultaneously ad-
justing for gender, age, and education ( Table 3 , lower panel). 
In both models, women were more likely to be frail than 
men and increasing age positively infl uenced the probabil-
ity of frailty, whereas additional years of education had a 
negative effect on this probability. After adjusting for demo-
graphics and education, only Sweden and Switzerland still 
had a signifi cantly different prevalence of frailty than the 
reference country at  p < .01 (Model 1). The combined prev-
alence of prefrailty and frailty (Model 2) was not lower in 
Sweden and Switzerland but was signifi cantly higher in 
Spain and Italy. 
 Discussion 
 Data from SHARE showed that signs of frailty were not 
rare in the middle-aged and were frequent in the older-aged 
community-dwelling population in Europe. The data also 
showed between-country differences in the distribution of a 
frailty phenotype. This survey was based on a large proba-
bility sample that included 50- to 64-year-old individuals, a 
group for which few studies provide estimates of frailty, and 
it relied on a standardized instrument, thus permitting inter-
national comparisons. 
 The prevalence of frailty in SHARE was higher than ex-
pected from reports of the landmark Cardiovascular Health 
Study (65+ years: men 4.9%, women 7.3% frail) ( 4 ), the 
Invecchiare  in Chianti study (65+ years: 8.8% frail) ( 14 ), the 
Osteoporotic Fractures in Men study (65+ years: 4% frail) 
( 13 ), the Women’s Health and Aging Studies (70 – 79 years: 
11.3% frail) ( 5 ), the Women’s Health Initiative study (65 – 79 
years: 16.3% frail) ( 6 ), or the Study of Osteoporotic Frac-
tures (69+ years: 16.3% frail) ( 11 , 12 ). However, other stud-
ies found higher estimates, such as the Hispanic Established 
Populations for the Epidemiologic Studies of the Elderly 
study (70+ years: 20%) ( 22 ) and the Massachusetts Male 
Aging Study (70 – 79 years: 11.0%; 80 – 86 years: 36.5%) 
( 23 ). Variations across studies may be due to methodologi-
cal differences that preclude direct comparison of the results. 
One variation is the protocol for excluding individuals with 
health conditions potentially related to frailty. SHARE did 
not exclude individuals on the basis of selected diseases, 
which could have resulted in higher proportions of frailty. A 
different operationalization of the dimensions of the frailty 
phenotype identifi ed by Fried and associates could be an-
other reason for variations in the estimated prevalence of 
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 Figure 1.  Percentage of the 65 years and older community-dwelling population classifi ed as prefrail and frail by country (weighted results). 
prefrailty and frailty. Criteria in SHARE were not identical 
to those defi ned in the Cardiovascular Health Study, except 
for weakness ( 4 ), and may be less specifi c, leading to higher 
prevalence estimates particularly for exhaustion, which was 
common in the SHARE population. The longitudinal design 
of SHARE will permit verifi cation of the predictive validity 
of frailty criteria assessed in this survey. A third method-
ological difference is the treatment of missing information. 
In the Cardiovascular Health Study, participants with miss-
ing information for less than two frailty components were 
considered evaluable, whereas SHARE data were analyzed 
only for participants with complete data for all components. 
The sensitivity analysis conducted on SHARE data showed 
that imputation tends to decrease the estimated proportion of 
nonfrail slightly; however, this effect was negligible. 
 Variations between European countries in the frequency 
of frailty are consistent with previous fi ndings of a north –
 south gradient characterizing other health indicators in 
SHARE ( 16 ). Lower rates of institutionalization of older dis-
abled persons in southern countries may be one explanation 
 
43.7%
36.6% 37.4%
32.9%
41.2%
45.6%
44.3%
48.8%
53.7%
45.8%
11.3%
21.0%
14.3%
9.3%
3.9%
6.6%
8.2%8.5%8.8%
5.9%
0%
10%
20%
30%
40%
50%
60%
S
w
ed
en
D
en
m
ar
k
N
et
he
rla
nd
s
G
er
m
an
y
A
us
tr
ia
S
w
itz
er
la
nd
F
ra
nc
e
Ita
ly
S
pa
in
G
re
ec
e
Pre-frail Frail
 
 Figure 2.  Percentage of the 65 years and older community-dwelling population without disability classifi ed as prefrail and frail by country (weighted results). 
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for a higher prevalence of frailty in their communities be-
cause frailty is strongly associated with disability. Organiza-
tion for Economic Co-operation and Development’s statistics 
( 24 ) indicated that there were 14.8 long-term care beds per 
1,000 inhabitants 65 years of age and older in Italy and 77.9 
in Sweden in 2003; however, we found that France ranked 
high in both long-term care bed density and frailty preva-
lence. Moreover, higher levels of frailty were also observed 
in the older nondisabled population and in the middle-aged 
population of southern countries. In contrast, a lower fre-
quency of frailty was noted in Switzerland and Sweden. Low 
participation may explain the favorable health indicators 
found for Switzerland, based on the assumption that the fi t-
test are more likely to participate in surveys. However, simi-
lar participation rates in Sweden, Spain, and Italy make this 
explanation less likely to account for the differences in frailty 
prevalence among these three countries. Like most other 
studies, we found a higher prevalence of frailty in women 
and in older-aged people. However, in between countries 
differences persisted after controlling for age and gender. 
Differences could also result from cultural characteristics 
infl uencing the perception of health or from misunderstand-
ings due to language differences despite considerable efforts 
invested in translation. However, although this explanation 
cannot be completely discarded, we found that objectively 
measured low grip strength contributed to the higher preva-
lence of frailty in Spain and Italy. 
 Although demographic characteristics did not explain in-
ternational differences in frailty, we found a strong relation-
ship between education and frailty, and an attenuation of 
country effects after adjusting for this factor. This illustrates 
the need to integrate nonmedical factors when studying the 
epidemiology of frailty. Although caution should be exer-
cised when interpreting our results due to the cross-sec-
tional study design, our data also suggest that education 
may protect from frailty at an individual level. This con-
verges with recent reports of a negative relationship be-
tween the level of education and the frequency of cognitive 
disorders in later life. Future studies should examine the 
extent to which differences in frailty between European 
countries mirror differences in the prevalence of cognitive 
impairments. 
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